Types of erythropoiesis-stimulating agents and risk of end-stage kidney disease and death in patients with non-dialysis chronic kidney disease
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Types of erythropoiesis-stimulating agents and risk of end-stage kidney disease and death in patients with non-dialysis chronic kidney disease
Authors
Keywords
-
Journal
NEPHROLOGY DIALYSIS TRANSPLANTATION
Volume -, Issue -, Pages -
Publisher
Oxford University Press (OUP)
Online
2020-04-01
DOI
10.1093/ndt/gfaa088
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Types of Erythropoietin-Stimulating Agents and Mortality among Patients Undergoing Hemodialysis
- (2019) Yusuke Sakaguchi et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Sex Differences in the Progression of CKD Among Older Patients: Pooled Analysis of 4 Cohort Studies
- (2019) Roberto Minutolo et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Cardiovascular Safety and All-Cause Mortality of Methoxy Polyethylene Glycol-Epoetin Beta and Other Erythropoiesis-Stimulating Agents in Anemia of CKD: A Randomized Noninferiority Trial
- (2019) Francesco Locatelli et al. Clinical Journal of the American Society of Nephrology
- Comparative efficacy and safety in ESA biosimilars vs. originators in adults with chronic kidney disease: a systematic review and meta-analysis
- (2017) Laura Amato et al. JOURNAL OF NEPHROLOGY
- Intravenous iron and erythropoiesis-stimulating agents in haemodialysis: A systematic review and meta-analysis
- (2017) Simon D Roger et al. NEPHROLOGY
- Evaluating the effectiveness of IV iron dosing for anemia management in common clinical practice: results from the Dialysis Outcomes and Practice Patterns Study (DOPPS)
- (2017) Bruce M. Robinson et al. BMC Nephrology
- Mortality Risk of Darbepoetin Alfa Versus Epoetin Alfa in Patients With CKD: Systematic Review and Meta-analysis
- (2015) Emilee R. Wilhelm-Leen et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Independent Role of Underlying Kidney Disease on Renal Prognosis of Patients with Chronic Kidney Disease under Nephrology Care
- (2015) Luca De Nicola et al. PLoS One
- Responsiveness to Erythropoiesis-Stimulating Agents in Chronic Kidney Disease: Does Geography Matter?
- (2014) Luca De Nicola et al. DRUGS
- Pharmacokinetic and pharmacodynamic considerations on the erythropoietin effect and adverse events of darbepoetin
- (2014) Frieder Keller et al. Expert Opinion on Drug Metabolism & Toxicology
- Cumulative iron dose and resistance to erythropoietin
- (2014) A. Rosati et al. JOURNAL OF NEPHROLOGY
- Anaemia management in non-dialysis chronic kidney disease (CKD) patients: a multicentre prospective study in renal clinics
- (2013) Roberto Minutolo et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- The development of anemia is associated to poor prognosis in NKF/KDOQI stage 3 chronic kidney disease
- (2013) José Portolés et al. BMC Nephrology
- Prognosis of CKD Patients Receiving Outpatient Nephrology Care in Italy
- (2011) L. De Nicola et al. Clinical Journal of the American Society of Nephrology
- Molecular Mechanisms of Hepcidin Regulation: Implications for the Anemia of CKD
- (2010) Jodie L. Babitt et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Prevalence and Prognosis of Mild Anemia in Non-Dialysis Chronic Kidney Disease: A Prospective Cohort Study in Outpatient Renal Clinics
- (2010) Luca De Nicola et al. AMERICAN JOURNAL OF NEPHROLOGY
- Conversion of Darbepoetin to Low Doses of CERA Maintains Hemoglobin Levels in Non-Dialysis Chronic Kidney Disease Patients
- (2010) Roberto Minutolo et al. BLOOD PURIFICATION
- International trends in erythropoietin use and hemoglobin levels in hemodialysis patients
- (2010) Philip A. McFarlane et al. KIDNEY INTERNATIONAL
- Maintenance treatment of renal anaemia in haemodialysis patients with methoxy polyethylene glycol-epoetin beta versus darbepoetin alfa administered monthly: a randomized comparative trial
- (2010) F. Carrera et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Erythropoietic Response and Outcomes in Kidney Disease and Type 2 Diabetes
- (2010) Scott D. Solomon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effect of a Low- Versus Moderate-Protein Diet on Progression of CKD: Follow-up of a Randomized Controlled Trial
- (2009) Bruno Cianciaruso et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- A Randomized Controlled Study of Weekly and Biweekly Dosing of Epoetin Alfa in CKD Patients With Anemia
- (2009) P. E. Pergola et al. Clinical Journal of the American Society of Nephrology
- Epoetin Therapy and Hemoglobin Level Variability in Nondialysis Patients with Chronic Kidney Disease
- (2009) R. Minutolo et al. Clinical Journal of the American Society of Nephrology
- Hemoglobin Variability in Nondialysis Chronic Kidney Disease: Examining the Association with Mortality
- (2009) N. C. Boudville et al. Clinical Journal of the American Society of Nephrology
- A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney Disease
- (2009) Marc A. Pfeffer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Greater Epoetin alfa Responsiveness Is Associated With Improved Survival in Hemodialysis Patients
- (2008) R. D. Kilpatrick et al. Clinical Journal of the American Society of Nephrology
- Maintenance of target hemoglobin level in stable hemodialysis patients constitutes a theoretical task: a historical prospective study
- (2008) José M. Portolés et al. KIDNEY INTERNATIONAL
- Secondary analysis of the CHOIR trial epoetin-α dose and achieved hemoglobin outcomes
- (2008) Lynda A. Szczech et al. KIDNEY INTERNATIONAL
- Anemia and anemia correction: surrogate markers or causes of morbidity in chronic kidney disease?
- (2008) Nosratola D Vaziri Nature clinical practice. Nephrology
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now